Cancer Research and Development
About Journal
Cancer Research and Development (CRD) is an international open-access journal that serves as a scholarly forum to publish high-quality research papers on recent developments in cancer science and research by scientists, researchers, and other health professionals. CRD publishes peer-reviewed scientific excellence manuscripts on various subjects related to cancer research, such as cancer identification, diagnosis, and treatment by innovative methods, cancer biomarkers, etc. It helps to keep cancer prevention, diagnosis, and care professionals, trainees, and researchers up to date. CRD offers a forum for the dissemination of quality research on all cancer types and associated biomedical science. New information and advances in cancer research, literature, and treatment are published. The Cancer Research and Development is an open-access journal with a rigorous policy of peer review and a fast method of publication.
About Journal
Cancer Research and Development (CRD) is an international open-access journal that serves as a scholarly forum to publish high-quality research papers on recent developments in cancer science and research by scientists, researchers, and other health professionals. CRD publishes peer-reviewed scientific excellence manuscripts on various subjects related to cancer research, such as cancer identification, diagnosis, and treatment by innovative methods, cancer biomarkers, etc.
It helps to keep cancer prevention, diagnosis, and care professionals, trainees, and researchers up to date. CRD offers a forum for the dissemination of quality research on all cancer types and associated biomedical science. New information and advances in cancer research, literature, and treatment are published. The Cancer Research and Development is an open-access journal with a rigorous policy of peer review and a fast method of publication.
In a wide variety of cancer-related issues, Cancer Research and Development covers basic, translational, and clinical research. The list is endless, so we hope that for all those involved in advancing the field in all its various ways, Cancer Research and Development will become a vehicle. Original research, study articles, clinical trials, editorials, expert opinion and perspective papers, opinions, book reviews, and meeting results will be featured in CRD.
Topics to be covered but not limited to
- Molecular Targets
- Molecular Basis of Cancer
- Stem Cell and Regenerative Medicine
- Tumour Immunology
- Cell Cycle and Checkpoints
- Nuclear Serine-Threonine Kinases
- Cancer Drug Discovery
- DNA Repair and Apoptosis
- Cancer Treatments
- Dental Cancer
- Lung Cancer
- Genitourinary Cancer
- Central Nervous System Tumors
- Head and Neck Cancer
- Skin Cancers
Editorial Board
Loading, please wait...
-
{{ e.editor.affiliation }}
{{ e.editor.qualification }}
{{ e.editor.university }}
In-Press
Loading, please wait...
{{ _.capitalize(article.article_type) }} Pubmed Full Text {{ article.publish_date }}
{{ article.corresponding_authors }}
Will be updated soon.
Current Issue
Loading, please wait...
{{ _.capitalize(article.article_type) }} Pubmed Full Text {{ article.publish_date }}
{{ article.corresponding_authors }}
No articles are in Current Issue now
Archive
Will be updated soon.
Publication Charges
Cancer Research and Development (CRD) is an Open Access publication and, when reading a manuscript or other document, we do not charge the end-user. This allows the scientific community, under the phrase "Creative Commons Attribution License" to access, download, distribute an article in any format, provided the original work is properly cited. We have a flat fee submission structure for the approval of a peer-reviewed article in line with other open access journals, covering in part the entire publication pathway (the article processing charge). The process involves our systems of maintenance, submission, and peer review and international editing, publishing, and submission to global organizations for indexing and monitoring, and archiving to enable immediate access to the entire article and related supplementary documents. To secure a sustainable model that is ethically, legally, and financially viable, we will have to ensure adequate investment.
The publishing fee for Cancer Research and Development is 499 GBP
Questions Also Asked (FAQs)
At these amounts, why are your charges set?
Open access to all papers written in the Geneft. Publishing Open Access means that all subscribers, anywhere in the world, are permitted immediately upon publication in Geneft Journals, without limitation to the full text of papers. The paper publication fees pay for the editorial and processing costs of the journal, the website hosting, the online printing of documents, the preparation of HTML, PDF, and XML versions of the articles.
Our financial targets are: to:
- Recover expenses for capitalization.
- Produce sufficient revenue to allow the ongoing creation of a sustainable and scalable publishing program
- Bend the expense of the publication-charge over time downwards.
Who is going to pay APC?
The payment must be made upon approval of the article by the corresponding author or co- authors.
When am I going to pay?
Upon acceptance of the paper, the corresponding author or the paying institution will receive an invoice and may arrange for the payment. For situations in which a wavier agreement was reached before submission, APC is removed.
As the papers will not be released until the payments have been charged, we ask for immediate attention to the payment.
How am I paying?
Authors or organizations, according to their convenience, may make payments in two ways.
- Wire/Bank Transfer
- Debit/ Credit Card
Note: no taxes are included in this fee; taxes are applicable in compliance with the policies of the payee's nation. There may be additional transaction charges imposed on the author.
May I apply for APC Wavier?
On a case-by-case basis, the waiver request will be assessed and will be given accordingly.
* Waiver requests must be submitted during the process of submission and will not be approved until the manuscript has been processed.
Do I need to Pay fee if I withdraw my paper?
The authors can withdraw the paper within two days of submission citing proper reason. If author wants to withdraw the manuscript after initiation of the review process, he needs to pay the withdrawal penalty which will be decided by the working editor based on the resources utilised for the manuscript.
Media Partner
